Kemble George

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kemble George's trades of Sagimet Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
9.57
Quantity 20,206
Value US$193,371
Transaction date
Proposed sale
Price
7.82
Quantity 18,844
Value US$147,360
Transaction date
Proposed sale
Price
7.85
Quantity 37,688
Value US$295,851
Transaction date
Proposed sale
Price
3.09
Quantity 23,625
Value US$73,001
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-14
PlS Planned sale
25,990 +11.8%
181.91
US$2,620,937 		25,990 +11.8% 181.91 US$2,620,937
2026-08-14 2026-08-14
PrS Proposed sale
4,480
390.70
US$955,234 		4,480 390.70 US$955,234
2026-08-12 2026-08-11
PlS Planned sale
36,788 +43.8%
10.42
US$3,201,282 		36,788 +43.8% 10.42 US$3,201,282
2026-08-11 2026-08-11
PrS Proposed sale
20,206
9.57
US$193,371 		20,206 9.57 US$193,371
2026-07-22 2026-07-20
PlS Planned sale
18,844 -23.3%
7.46
US$140,529 		18,844 -23.3% 7.46 US$140,529
2026-07-20 2026-07-20
PrS Proposed sale
18,844
7.82
US$147,360 		18,844 7.82 US$147,360
2025-11-21 2025-11-20
PlS Planned sale
37,688 -31.8%
7.69
US$289,979 		37,688 -31.8% 7.69 US$289,979
2025-11-20 2025-11-20
PrS Proposed sale
37,688
7.85
US$295,851 		37,688 7.85 US$295,851
2024-07-25 2024-07-23
PlS Planned sale
23,625 -16.6%
3.17
US$74,830 		23,625 -16.6% 3.17 US$74,830
2024-07-23 2024-07-23
PrS Proposed sale
23,625
3.09
US$73,001 		23,625 3.09 US$73,001
2024-07-23 2024-07-19
S Sale
14,062 -9.0%
3.10
US$43,605 		14,062 -9.0% 3.10 US$43,605